International authorities sour on COVID boosters, while FDA promotes them for recovered people
“We should be careful in not overloading the immune system with repeated immunization,” European Medicines Agency official warns
International authorities are falling out of love with boosters as a COVID-19 mitigation strategy, even as U.S. regulators continue unqualified promotion of the third shot for mRNA vaccines and second for Johnson & Johnson’s downgraded vaccine.
Reconsideration of the booster binge comes amid further scrutiny of rare but higher-than-expected — and possibly undercounted — heart inflammation reports following vaccination, particularly in boys and young men.
The World Health Organization all but accused wealthier countries of hoarding shots while large swaths of the globe, particularly Africa, have not received the “primary series” of vaccination against COVID.
Its Technical Advisory Group on COVID-19 Vaccine Composition released an interim statement Tuesday on how the rise of the mild but immune-evasive Omicron variant should change booster considerations.
Even though Omicron’s “mutational profile and preliminary data indicate that vaccine effectiveness will be reduced against symptomatic disease … protection against severe disease is more likely to be preserved,” TAG-CO-VAC said.
Given the “near- and medium-term supply of the available vaccines” and consideration of equity, demand and viral evolution, “a vaccination strategy based on repeated booster doses of the original vaccine composition is unlikely to be appropriate or sustainable,” it said.
TAG-CO-VAC asked vaccine manufacturers to study immune responses to single-strain and multi-strain vaccines against so-called variants of concern, including Omicron. The goal is developing more powerful vaccines that “reduce the need for successive booster doses.”
For European regulators, the problem is the boosters themselves, at least on such a frequent schedule.
“If we have a strategy in which we give boosters, let’s say, every four months approximately … immune response may end up not being as good as we would like it to be,” vaccines strategy chief Marco Cavaleri said at a European Medicines Agency briefing Tuesday.
“We should be careful in not overloading the immune system with repeated immunization,” but also there’s a “risk of fatiguing the population with a continuous administration of boosters,” he said, calling for longer gaps between shots.
European Medicines Agency’s Head of Vaccines Strategy, Marco Cavaleri: “If we have a strategy in which we give boosters every four months, we will end up having problems with immune response” 👀 pic.twitter.com/uHP71dfRa6
— Julija 🌹🌹🌹 (@Julija9j) January 12, 2022
The agency recommended tying boosters to the start of the cold season in each hemisphere, in line with influenza vaccination strategies, Bloomberg reported. Earlier this month, Israel became the first country to administer second boosters — the fourth shot — for populations over 60.
The U.S. CDC recommends waiting at least five months after the Pfizer and Moderna vaccines and two months after Johnson & Johnson to get boosters, meaning Americans could get two or more boosters in less than a year.
The national public health agency didn’t respond to Just the News requests to defend that schedule in light of international reconsideration of booster strategies.
The CDC’s sister agency, the FDA, is trying to expand the boosted population even further, by claiming that people who recovered from COVID and then got vaccinated are still vulnerable.
Natural immunity from early in the pandemic is based on “a different variant than what’s circulating right now,” Center for Biologics Evaluation and Research Director Peter Marks claimed in a slick video with cartoon graphics and a jazz soundtrack.
If you’ve had #COVID19, but you haven’t had a booster yet, our own Dr. Peter Marks wants “Just a Minute” of your time. pic.twitter.com/9dZFMXTOsk
— U.S. FDA (@US_FDA) January 5, 2022
“And we know that you need high levels of immunity, such as those that would be provided by a booster,” he said. These people should consult with their medical provider on “when the time is right” for a booster, which “can help prevent you from getting into further trouble with a new variant.”
High-profile medical critics of the feds’ COVID policy laced into the FDA. The video is “extremely misleading and based on the dogma that antibody titers are the key indicator of protection,” Johns Hopkins medical professor Marty Makary tweeted.
“Many government doctors have lost their scientific objectivity. And sadly ignore the overwhelming data on natural immunity,” the National Academy of Medicine member said.
University of California San Francisco medical professor Vinay Prasad called the video “madness” and said he reported it to Twitter as misinformation.
Recommending boosters based on old infections ignores the fact that those boosters are based on an “[o]lder ancestral strain” of COVID, he tweeted.
Marks himself knows “there is no evidence to support” the need for a booster for recovered people, because the FDA didn’t ask vaccine makers to “run robust randomized control trials powered for clinical endpoints for boosters.”
Done! Let us see what they do pic.twitter.com/FWiI7K3BgB
— Vinay Prasad, MD MPH 🎙️📷 (@VPrasadMDMPH) January 5, 2022
The agency has resorted to “low levels of evidence aka storytelling to change the public’s behavior” since Director Marion Gruber and Deputy Director Philip Krause of the FDA’s Office of Vaccines Research & Review resigned this fall, reportedly in protest of the administration’s plans for boosters, Prasad said.
Krause joined a public letter warning of “risks if boosters are widely introduced too soon, or too frequently,” and cowrote an op-ed accusing the agency of “sidelining vaccine experts.”
The FDA didn’t answer queries from Just the News to respond to the accusations from Makary and Prasad.
Some medical experts also argued against boosters for teenagers due to their elevated heart-inflammation risks in interviews with Atlantic writer Rachel Gutman published Tuesday.
University of Pittsburgh medical professor Walid Gellad pointed her to a Kaiser Permanente Northwest preprint study, not yet peer-reviewed, that concluded the true number of myopericarditis cases is “markedly higher” than what’s reported to U.S. advisory committees.
Boosters aren’t worth the risks for, say, a 17-year-old male who is generally healthy, or for his own 20-something son, according to Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia.
Omicron’s immune evasion does not appear to meaningfully reduce the protection against serious illness from two-dose vaccines, Offit said.
While Gutman mostly featured pro-booster doctors and claimed the benefits of two-dose vaccines for teens “are beyond question,” heart-inflammation reports overwhelmingly follow the second dose.
That’s why Prasad among others has recommended a single or smaller dose for young people, claiming that the “marginal risks in teens” from second doses “appear likely to exceed their marginal benefits.”
(TLB) published this article with permission of John Solomon at Just the News. Click Here to read about the staff at Just the News
Some emphasis and pictorial content added by (TLB)
Header featured image (edited) credit: Dr. Marks/Twitter grab
Stay tuned to …
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Likewise, as the noose tightens around the narrative, betrayal of criminals by criminals under cover of plausible deniability will pull the lever to hang the narrative by the neck until dead.
They already have the money, now they need to escape justice. This scenario is ripe for betrayal.
Well, I’m guessing that the payments from Big Pharma are dropping off, or that officials are getting more greedy. Tens of billions of tax dollars are being distributed to politicians and bureaucrats around the world….maybe they just want more. Because, up to this point they haven’t given a damn about health…just control.